JAY M MOYES
CIK 1191062 · Chief Financial Officer · last filed 2026-02-25
JAY M MOYES is a Chief Financial Officer who has filed 76 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing shows the insider bought $2.9K of SINT on Feb 25, 2026. Across all open-market trades the lifetime net is −$7.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $579.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$579.6K
10
76
-$7.04M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SINT | Director | 4,000 | $2.12 | $8.5K | $13.7K | 2 | 2026-02-25 |
| BCDA | Director | — | $0.88 | — | $0 | 5 | 2025-12-10 |
| PBYI | Director | 53,322 | $7.33 | $390.9K | -$760.8K | 21 | 2025-06-17 |
| BioCardia, Inc. (BCDAW) Delisted | Director | 54,267 | $0.01 | $331 | $0 | 10 | 2023-10-19 |
| SERA | Chief Financial Officer | 35,630 | $1.87 | $66.6K | $0 | 3 | 2023-03-07 |
| ACHV | Director | — | $5.52 | — | $0 | 6 | 2022-06-01 |
| ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted | Director | — | — | — | $0 | 1 | 2017-08-03 |
| Sintx Technologies, Inc. (AMDA) Delisted | Chief Financial Officer | 66,562 | — | — | $0 | 1 | 2014-02-21 |
| OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Director | 26,500 | — | — | $0 | 8 | 2014-02-07 |
| MYGN | Chief Financial Officer | 26,256 | $4.33 | $113.7K | -$6.29M | 18 | 2007-10-16 |
Recent Filings
76 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-25 | SINT | Buy (P) | +1,000 | $2.9K | EDGAR |
| 2025-12-10 | BCDA | Grant (A) | — | $0 | EDGAR |
| 2025-08-27 | SINT | Buy (P) | +3,000 | $10.8K | EDGAR |
| 2025-06-17 | PBYI | Sell (S) | −22,000 | -$74.8K | EDGAR |
| 2025-06-13 | PBYI | Grant (A) | +27,000 | $0 | EDGAR |
| 2024-10-16 | BCDA | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | PBYI | Grant (A) | +27,000 | $0 | EDGAR |
| 2024-06-17 | PBYI | Sell (S) | −22,000 | -$73.5K | EDGAR |
| 2023-10-19 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | PBYI | Mixed | +5,000 | -$76.0K | EDGAR |